Ablative approach for primary liver cancer: Shanghai experience

Area of Science:

• Hepatology
• Surgical Oncology
• Oncology

Background:

• Primary liver cancer (PLC) presents significant treatment challenges.
• Surgical intervention is a key modality for managing PLC.
• Unresectable PLC requires specialized therapeutic approaches.

Purpose of the Study:

• To summarize surgical treatment outcomes in a large cohort of PLC patients.
• To evaluate the efficacy of cryosurgery and cytoreduction for unresectable PLC.
• To provide insights into current surgical management strategies for primary liver cancer.

Main Methods:

• Retrospective analysis of 2018 patients undergoing surgical treatment for pathologically confirmed PLC.
• Review of treatment protocols, including cryosurgery and cytoreduction.
• Assessment of patient outcomes and oncological results.

Main Results:

• Surgical treatment was administered to 2018 patients with pathologically proven primary liver cancer.
• Cryosurgery and cytoreduction were specifically considered for patients with unresectable PLC.
• Outcomes data were analyzed to assess the impact of surgical interventions.

Conclusions:

• Surgical treatment plays a vital role in managing primary liver cancer.
• Cryosurgery and cytoreduction offer potential therapeutic options for unresectable PLC.
• Further research into optimizing surgical techniques for PLC is warranted.